Gabriella Gobbi /newsroom/taxonomy/term/1452/all en LSD may offer viable treatment for certain mental disorders /newsroom/channels/news/lsd-may-offer-viable-treatment-certain-mental-disorders-328008 <p>Researchers from ³ÉÈËVRÊÓƵ have discovered, for the first time, one of the possible mechanisms that contributes to the ability of lysergic acid diethylamide (LSD) to increase social interaction. The findings, which could help unlock potential therapeutic applications in treating certain psychiatric diseases, including anxiety and alcohol use disorders, are published in the journal <i>PNAS</i>.</p> Tue, 26 Jan 2021 14:46:16 +0000 katherine.gombay@mcgill.ca 256571 at /newsroom New use for an old drug: How does ketamine combat depression? /newsroom/channels/news/new-use-old-drug-how-does-ketamine-combat-depression-327092 <p>A group of proteins called 4E-BPs, involved in memory formation, is the key to unlocking the antidepressant effect of ketamine in the brain, according to researchers from three Canadian universities. The <a href="https://www.nature.com/articles/s41586-020-03047-0">discovery</a> could lead to better and safer treatments for certain patients suffering from major depression.</p> Tue, 15 Dec 2020 23:38:03 +0000 shirley.cardenas@mcgill.ca 253379 at /newsroom Supreme Court ruling about Medical Marijuana /newsroom/channels/news/supreme-court-ruling-about-medical-marijuana-253513 <p> Thu, 11 Jun 2015 19:03:49 +0000 melody.enguix@mcgill.ca 24227 at /newsroom